Biomedical Science Letters

eISSN 2288-7415

Table. 5.

O-serogroup, virulence factors and phylogenetic group of uropathogenic E. coli isolated from patient with urinary tract infections in 1989 and 2010-2014

O-serogroup Year Virulence factors Phylogenetic group
fimG/H sfaD/E papC usp cnf1 hlyA A B1 B2 D Total
O1 1989 6 (100%) 2 (33.3%) 2 (33.3%) 5 (83.3%) - - - - - 6 6 (4.9%)
2010-2014 36 (90%) 4 (10%) 12 (57.5%) 3 (7.5%) 8 (20%) 4 (10%) - - 20 20 40 (7.2%)
O2 1989 3 (100%) 3 (100%) 1 (33.3%) 2 (66.7%) 3 (100%) 2 (66.7%) - - 3 - 3 (2.4%)
2010-2014 68 (98.6%) 19 (27.5%) 63 (91.3%) 8 (11.6%) 24 (34.8%) 3 (4.3%) - - 65 4 69 (12.4%)
O4 1989 2 (100%) 2 (100%) 2 (100%) 2 (100%) 2 (100%) 1 (57.1%) 1 - 2 - 3 (2.4%)
2010-2014 9 (100%) 5 (55.6%) 4 (44.4%) 4 (44.4%) 5 (55.6%) 3 (33.3%) 1 2 6 - 9 (1.6%)
O6 1989 11 (78.6%) 8 (57.1%) 8 (57.1%) 9 (64.3%) 8 (57.1%) 8 (57.1%) 5 - 9 - 14 (11.4%)
2010-2014 43 (100%) 30 (69.8%) 27 (62.8%) 26 (60.5%) 30 (69.8%) 25 (58.1%) 2 2 30 9 43 (7.7%)
O7 1989 1 (100%) - - - - - - - - 1 1 (0.8%)
2010-2014 3 (60%) 1 (20%) 1 (20%) 1 (20%) - - 2 - 1 2 5 (0.9%)
O8 1989 6 (66.7%) - 1 (11.1%) - - - 2 2 1 4 9 (7.3%)
2010-2014 17 (85%) 3 (15%) 1 (5%) 2 (10%) 2 (10%) - 5 6 7 2 20 (3.6%)
O15 1989 - - - - - - - - - - -
2010-2014 17 (89.5%) 1 (5.3%) 9 (47.4%) 3 (15.8%) 8 (42.1%) 1 (5.3%) 4 - 2 13 19 (3.4%)
O16 1989 - - - - - - - - - - -
2010-2014 14 (100%) - 4 (28.6%) - - 1 (7.1%) 2 - 9 3 14 (2.5%)
O18 1989 - - - - - - - - - - -
2010-2014 15 (100%) 2 (13.3%) 3 (20%) 6 (40%) 4 (26.7%) 3 (20%) 3 1 6 5 15 (2.7%)
O21 1989 4 (100%) - 4 (100%) 3 (75.0%) - 4 (100%) - - 4 - 4 (3.3%)
2010-2014 3 (100%) 1 (33.3%) 1 (33.3%) - 1 (33.3%) 1 (33.3%) 1 1 - 1 3 (0.5%)
O22 1989 - - - - - - - - - - -
2010-2014 5 (100%) - 1 (20%) 2 (40%) - - - - 2 3 5 (0.9%)
O25 1989 12 (100%) - - 2 (16.7%) - - - - 9 3 12 (9.8%)
2010-2014 110 (94%) 12 (10.3%) 37 (31.6%) 10 (8.5%) 24 (20.5%) 17 (14.5%) 7 5 96 9 117 (21.0%)
O75 1989 12 (100%) 1 (8.3%) 6 (50.0%) 8 (66.7%) 1 (8.3%) 2 (16.7%) 1 1 8 2 12 (9.8%)
2010-2014 57 (95%) 1 (1.7%) 2 (3.3%) 56 (93.3%) 10 (16.7%) - 1 - 57 2 60 (10.8%)
O83 1989 4 (100%) - - 2 (50.0%) - - - - 4 - 4 (3.3%)
2010-2014 2 (66.7%) 1 (33.3%) 1 (33.3%) 1 (33.3%) - - 1 - 2 - 3 (0.5%)
Other serogroup 1989 42 (76.4%) - 2 (3.6%) 10 (18.2%) - 2 (3.6%) 21 8 7 19 55 (44.7%)
2010-2014 118 (86.8%) 19 (14%) 31 (22.8%) 30 (22.1%) 30 (22.1%) 10 (7.4%) 27 13 42 54 136 (24.4%)
Biomed Sci Letters 2022;28:127-36 https://doi.org/10.15616/BSL.2022.28.2.127
© 2022 Biomed Sci Letters